About Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical contract research organisation developing, validating and delivering custom assays. With over 200 staff including 120+ scientists across laboratories in Manchester, Turku and Cape Town, the company supports pharmaceutical, biotech and academic partners from discovery through regulatory submission. Services span biomarker identification, clinical bioanalysis, flow cytometry, mass spectrometry and immunoassays. The company translates biological hypotheses into regulatory compliant data. By integrating into client teams, Synexa reduces trial risk, validates therapeutic biology in disease models, and delivers mechanistic data across pharmacokinetics, immunogenicity and biomarker endpoints.